The higher-cost US system of cancer care delivery may be worth it, although further research is required to determine what specific tools or treatments are driving improved cancer survival in the United States.
Assessments of the medical and economic value of therapies in diseases such as cancer traditionally focus on average or median gains in patients' survival.
The addition of oxaliplatin to 5-FU appears to be associated with better survival among patients receiving adjuvant colon cancer treatment in the community.
Physician co-management, representing joint participation in the planning, decision-making, and delivery of care, is often cited in association with coordination of care. Yet little is known about how physicians manage tasks and how their management style impacts patient outcomes.
Experts agree on many key issues regarding anaplastic large cell lymphoma in women with breast implants, but substantial research is needed to improve our understanding of the epidemiology, clinical aspects, and biology of this disease.
US and Canadian differences in cancer screening due to each country's guidelines can potentially explain cross-country differences in breast cancer mortality and affect interpretation of international comparisons of cancer statistics.
Breast implants appear to be associated with a rare form of lymphoma, but there is not yet evidence to show that the cancer is caused by implants or to suggest an underlying mechanism for how the disease might develop.
Decreased use of myeloid colony-stimulating factors in patients at lower or intermediate risk of febrile neutropenia from high-risk chemotherapy regimens could yield substantial cost savings without compromising patient outcomes.
Stories discuss gays in the military, police recruitment, home health care, breast cancer, health insurance exchanges, alternative fuels, refinery taxes, alcohol prices, outer space debris, mental illness, diplomatic trends, and health care costs.
In terms of healthcare use and chronic health conditions, obesity is comparable to aging 20 years, with the health of a 30 year old resembling that of a 50 year old, writes Roland Sturm.
A RAND Corporation review of the literature suggests that breast implants are associated with a rare form of lymphoma, but an expert panel believes that the disease can be managed by surgical removal of the implant.
Breast implants appear to be associated with a rare form of lymphoma, but there is not yet evidence to show that the cancer is caused by implants or to suggest an underlying mechanism for how the disease might develop.
The use of patient navigators-individuals who perform outreach, coordination, and education across language and cultural barriers-improved breast cancer quality of care in a public hospital and may help reduce disparities in quality of cancer care.
